Literature DB >> 15276117

Endothelial cell function in patients with Down's syndrome.

Maurizio Cappelli-Bigazzi1, Giuseppe Santoro, Carmine Battaglia, Maria Teresa Palladino, Marianna Carrozza, Maria Giovanna Russo, Giuseppe Pacileo, Raffaele Calabrò.   

Abstract

Patients with Down's syndrome show an increased pulmonary vascular reactivity that could be due to an impaired vascular endothelial function, which is possibly related to increased oxidative stress. In 8 patients with Down's syndrome and 9 euploid patients of similar age, endothelium-dependent and -independent vasodilation was studied, measuring brachial flow velocity with an intravascular Doppler flow wire. Patients with Down's syndrome showed a significant impairment of endothelial function versus controls. In presence of the antioxidant vitamin C, endothelium-dependent vasodilation in the patients with Down's syndrome was only slightly, but not significantly, improved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276117     DOI: 10.1016/j.amjcard.2004.04.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates.

Authors:  C L Cua; A Blankenship; A L North; J Hayes; L D Nelin
Journal:  Pediatr Cardiol       Date:  2007-05-05       Impact factor: 1.655

2.  Prevalence and profile of congenital heart disease and pulmonary hypertension in Down syndrome in a pediatric cardiology service.

Authors:  Felipe Alves Mourato; Lúcia Roberta R Villachan; Sandra da Silva Mattos
Journal:  Rev Paul Pediatr       Date:  2014-06

Review 3.  Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.

Authors:  Emanuele Marzetti; Anna Csiszar; Debapriya Dutta; Gauthami Balagopal; Riccardo Calvani; Christiaan Leeuwenburgh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

4.  Plasma endothelin-1 and nitrate levels in Down's syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down's syndrome children.

Authors:  Metin Sungur; Burhan Ocal; Deniz Oğuz; Selmin Karademir; Cemşit Karakurt; Filiz Senocak
Journal:  Eur J Pediatr       Date:  2008-08-06       Impact factor: 3.183

5.  Peripheral blood flow regulation in response to sympathetic stimulation in individuals with Down syndrome.

Authors:  Thessa I M Hilgenkamp; Sang Ouk Wee; Elizabeth C Schroeder; Tracy Baynard; Bo Fernhall
Journal:  Artery Res       Date:  2018-10-24       Impact factor: 0.597

6.  Cardiovascular physiology and pathophysiology in Down syndrome.

Authors:  B T Cilhoroz; C N Receno; K S Heffernan; L R Deruisseau
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

7.  Risk factors for respiratory adverse events after adenoidectomy and tonsillectomy in children with down syndrome: a retrospective cohort study.

Authors:  Lena Xiao; Nicholas Barrowman; Franco Momoli; Kimmo Murto; Matthew Bromwich; Sherri L Katz
Journal:  Eur J Pediatr       Date:  2022-03-12       Impact factor: 3.183

8.  Impairment of circulating endothelial progenitors in Down syndrome.

Authors:  Valerio Costa; Linda Sommese; Amelia Casamassimi; Roberta Colicchio; Claudia Angelini; Valentina Marchesano; Lara Milone; Bartolomeo Farzati; Alfonso Giovane; Carmela Fiorito; Monica Rienzo; Marco Picardi; Bice Avallone; Massimiliano Marco Corsi; Berardo Sarubbi; Raffaele Calabrò; Paola Salvatore; Alfredo Ciccodicola; Claudio Napoli
Journal:  BMC Med Genomics       Date:  2010-09-13       Impact factor: 3.063

9.  Severe pulmonary artery hypertension following intracardiac repair of tetralogy of Fallot: An unusual finding.

Authors:  Bhupesh Kumar; Goverdhan D Puri; Rohit Manoj; Kirti Gupta; K S Shyam
Journal:  Pulm Circ       Date:  2011 Jan-Mar       Impact factor: 3.017

10.  Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.

Authors:  Maurice Beghetti; Andrzej Rudzinski; Min Zhang
Journal:  BMC Cardiovasc Disord       Date:  2017-07-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.